AriaFlow is an AI document assembly platform for pharmaceutical medical and regulatory teams. It helps turn approved evidence, existing templates, and review logic into structured, traceable, review-ready documents, while keeping experts responsible for interpretation and decisions. Rather than generating isolated text, the platform brings sources, specialized AI agents, controlled templates, review steps, and approvals into a governed workflow.

AriaFlow can be configured for a range of regulated documents, including eCTD content, AMNOG dossiers, periodic safety update reports (PSURs), risk management plans (RMPs), summaries of product characteristics (SmPCs), and pediatric investigation plans (PIPs). It also supports annual product quality review drafts, health technology assessment gap analyses, and ICH E3-compliant clinical study report drafts.

Teams can use their existing business templates, connect document creation with reviews and decision gates, and incorporate reviewed edits to improve future drafts. AriaFlow is supported by regulatory, implementation, and workflow expertise, including through partners G&L Scientific and Entourage. Its approach aims to reduce document assembly work and help experts focus on evidence gaps, interpretation, and accountable decisions.